This hypothetical example assumes that the reference biologic’s ASP (average sales price) is 20% less than the WAC (wholesale acquisition cost) based on rebates over time.
Citation formats
Physician office payment for biosimilars in Medicare Part B 2022
This statistic shows a hypothetical example of physician office payments for biosimilars in Medicare Part B as of 2022. The wholesale acquisition cost (WAC) for the reference drug would be one thousand U.S. dollars, while the WAC for biosimilar A would be 200 dollars lower.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Amgen. (October 31, 2022). Example of physician office payment for biosimilars in Medicare Part B as of 2022 (in U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 26, 2026, from /statistics/700131/physician-office-payment-for-biosimilars-in-medicare-part-b/
Amgen. "Example of physician office payment for biosimilars in Medicare Part B as of 2022 (in U.S. dollars)." Chart. October 31, 2022. ÌÇÐÄÆƽâ°æ. Accessed July 26, 2026. /statistics/700131/physician-office-payment-for-biosimilars-in-medicare-part-b/
Amgen. (2022). Example of physician office payment for biosimilars in Medicare Part B as of 2022 (in U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 26, 2026. /statistics/700131/physician-office-payment-for-biosimilars-in-medicare-part-b/
Amgen. "Example of Physician Office Payment for Biosimilars in Medicare Part B as of 2022 (in U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 31 Oct 2022, /statistics/700131/physician-office-payment-for-biosimilars-in-medicare-part-b/
Amgen, Example of physician office payment for biosimilars in Medicare Part B as of 2022 (in U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/700131/physician-office-payment-for-biosimilars-in-medicare-part-b/ (last visited July 26, 2026)
Example of physician office payment for biosimilars in Medicare Part B as of 2022 (in U.S. dollars) [Graph], Amgen, October 31, 2022. [Online]. Available: /statistics/700131/physician-office-payment-for-biosimilars-in-medicare-part-b/
